CD274 and head and neck squamous cell carcinoma: These therapies have shown better outcomes in terms of overall survival (OS) and progression-free survival (PFS) relative to standard chemotherapy, with the greatest benefits observed in HNSCC cases with elevated levels of PD-L1 [7, 12].